Online Journal
Front Page 
 
 Donate
 
 Submissions
 
 Announcements
 
 NewsLinks
 
 Special Reports
 
 News Media
 
 Elections & Voting
 
 Health
 
 Religion
 
 Social Security
 
 Analysis
 
 Commentary
 
 Editors' Blog
 
 Reclaiming America
 
 The Splendid Failure of Occupation
 
 The Lighter Side
 
 Reviews
 
 The Mailbag
 
 Online Journal Stores
 Official Merchandise
 Amazon.com
 
 Links
 
 Join Mailing List
Search

Health Last Updated: Jan 16th, 2007 - 01:37:21


Drug reimportation is back in the news: It should happen. But it won't.
By Peter Rost, M.D.
Online Journal Contributing Writer


Jan 16, 2007, 01:30

Email this article
 Printer friendly page

Drug reimportation is back in the headlines.

What brought this issue back to life was the introduction of two identical bills in the House of Representatives and the U.S. Senate to legalize importation of less expensive prescription drugs into the United States.

The fight for affordable drugs in the U.S., where uninsured patients pay the highest prices in the world, has gone on for a long time, with very little result.

A 2004 study by the U.S. Congressional Budget Office found that comparable drugs sold for 35 to 55 per cent less in Canada than in the U.S. The only ones benefiting from this situation have been the drug companies, and Canadian Internet pharmacies, which supply drugs to about 3 million Americans.

The proposed legislation would allow U.S. licensed pharmacies and wholesalers to import medications from Canada, Europe, Japan, Australia, and New Zealand.

Is it going to happen?

I doubt it.

The last time I was involved with this issue, Senator Byron L. Dorgan (D-ND) told me it was definitely going to happen. It didn't.

What is different this time around is that Democrats are now controlling both Houses, so the legislation stands a better chance of being passed.

What is not different is that to become law the new legislation must be approved by President Bush, and he's made it very clear that he will not sign such legislation.

The issue seems like a no-brainer. But too many people in our government are paid off and will not allow this to happen, no matter how many uninsured Americans are suffering.

There is, however, some hope: Another presidential election is around the corner.

Peter Rost, M.D., is a former Vice President of Pfizer. He is the author of "The Whistleblower, Confessions of a Healthcare Hitman." He also writes the daily Dr. Peter Rost blog.

Copyright © 1998-2007 Online Journal
Email Online Journal Editor

Top of Page

Health
Latest Headlines
Medicare Part D destroys the lives of senior citizens, the poor, and the sick
Eli Lilly's latest curse: Cymbalta
FDA, industry insiders derail approval of new cancer treatments
The topic of cancer
Why Bush should have signed the children�s health act
S-CHIP veto: The millstone around Bush's neck
Canada unveils mental health board: Prime Minister Harper�s cure worse than disease
Setting the record straight: observations on universal health care from actual Canadians
Avandia's real warning should be about the FDA and Big Pharma symbiosis
AMA sics drug salesmen on doctors, charge groups at annual meeting
Alone in the industrialized world: The American healthcare system
The 2003 Medicare Privatization Act
Did Abraxis BioScience instruct AstraZeneca to use illegal marketing in their quest to increase sales?
Activists take on Eli Lilly over off-label sale of Zyprexa
More Zyprexa postcards from the edge
Judge in Zyprexa secret document case invites New York Times reporter to hearing
Drug reimportation is back in the news: It should happen. But it won't.
FDA runs protection racket for Big Pharma
JAMA's Fosamax study funded by Merck
Criminal prosecution of Lilly sought over Zyprexa